ID22904A - Penghambat serin protease - Google Patents

Penghambat serin protease

Info

Publication number
ID22904A
ID22904A IDW991290A ID991290A ID22904A ID 22904 A ID22904 A ID 22904A ID W991290 A IDW991290 A ID W991290A ID 991290 A ID991290 A ID 991290A ID 22904 A ID22904 A ID 22904A
Authority
ID
Indonesia
Prior art keywords
obstacles
serin protease
serin
protease
protease obstacles
Prior art date
Application number
IDW991290A
Other languages
English (en)
Inventor
Anton Egbert Peter Adang
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ID22904A publication Critical patent/ID22904A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
IDW991290A 1997-05-02 1998-04-28 Penghambat serin protease ID22904A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201286 1997-05-02

Publications (1)

Publication Number Publication Date
ID22904A true ID22904A (id) 1999-12-16

Family

ID=8228278

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991290A ID22904A (id) 1997-05-02 1998-04-28 Penghambat serin protease

Country Status (23)

Country Link
US (1) US6534495B1 (id)
EP (1) EP0979240B1 (id)
JP (1) JP2001524117A (id)
KR (1) KR20010012174A (id)
CN (1) CN1254345A (id)
AR (1) AR012631A1 (id)
AT (1) ATE264339T1 (id)
AU (1) AU729910B2 (id)
BR (1) BR9809342A (id)
CA (1) CA2287569A1 (id)
DE (1) DE69823178T2 (id)
DK (1) DK0979240T3 (id)
ES (1) ES2218827T3 (id)
HU (1) HUP0002942A3 (id)
ID (1) ID22904A (id)
NO (1) NO995316D0 (id)
NZ (1) NZ500620A (id)
PL (1) PL336589A1 (id)
PT (1) PT979240E (id)
RU (2) RU2183642C2 (id)
TR (1) TR199902692T2 (id)
WO (1) WO1998050420A1 (id)
ZA (1) ZA983629B (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
CA2358578A1 (en) 1999-01-02 2000-07-13 Aventis Pharma Deutschland Gmbh Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity)
US6344450B1 (en) * 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
WO2000051624A2 (en) 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
US6723711B2 (en) 1999-05-07 2004-04-20 Texas Biotechnology Corporation Propanoic acid derivatives that inhibit the binding of integrins to their receptors
TR200103427T2 (tr) * 1999-05-07 2002-10-21 Texas Biotechnology Corporation Integrinlerin reseptörlerine bağlanmasını engelleyen propanoik asit türevleri.
US6664255B1 (en) 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6458952B1 (en) 1999-05-19 2002-10-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
JP2000344739A (ja) 1999-06-01 2000-12-12 Sumitomo Chem Co Ltd N−保護−アゼチジン−2−カルボン酸の製造方法
CA2390349A1 (en) * 1999-12-03 2001-06-07 Bristol-Myers Squibb Pharma Company Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
EP1127884A1 (en) 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
AU2001243598A1 (en) 2000-03-13 2001-09-24 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
US6875791B2 (en) 2000-04-05 2005-04-05 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
AU2001251315A1 (en) 2000-04-05 2001-10-23 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
US20040171616A9 (en) 2000-04-17 2004-09-02 South Michael S. Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
WO2002042272A2 (en) 2000-11-20 2002-05-30 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
JP2004518688A (ja) 2001-01-30 2004-06-24 ブリストル−マイヤーズ スクイブ カンパニー ファクターXa阻害剤のスルホンアミドラクタムおよびその方法
GB0119370D0 (en) * 2001-08-08 2001-10-03 Univ London Therapeutic agent
DK1418905T3 (da) 2001-08-08 2007-09-10 Pentraxin Therapeutics Ltd Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma
AU2002367752A1 (en) 2001-10-03 2003-11-17 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
WO2003029216A1 (en) 2001-10-03 2003-04-10 Pharmacia Corporation 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
GB0313386D0 (en) 2003-06-10 2003-07-16 Univ London Treatment of disease
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
KR101069051B1 (ko) 2006-05-23 2011-09-29 아이알엠 엘엘씨 채널 활성화 프로테아제 억제제로서의 화합물 및 조성물
BRPI0807483A2 (pt) 2007-02-09 2014-05-13 Irm Llc Compostos e composições como inibidores de protease de ativação de canal
EP2405925B1 (en) 2009-03-10 2015-01-14 Med Discovery Sa Kallikrein inhibitors for the treatment of neutropenia
MX2020010034A (es) * 2018-03-28 2020-10-14 Blade Therapeutics Inc Metodo de tratamiento de enfermedad fibrotica.
DE102020103516B4 (de) 2020-02-11 2023-12-07 Universität Zu Lübeck Antivirale Wirkstoffe mit breiter Aktivität

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
IL119466A (en) * 1995-11-03 2001-08-26 Akzo Nobel Nv Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
WO1998009987A1 (en) * 1996-09-06 1998-03-12 Biochem Pharma, Inc. Lactam inhibitors of thrombin

Also Published As

Publication number Publication date
PT979240E (pt) 2004-08-31
HUP0002942A3 (en) 2001-12-28
AR012631A1 (es) 2000-11-08
DE69823178T2 (de) 2005-06-23
JP2001524117A (ja) 2001-11-27
TR199902692T2 (xx) 2000-07-21
DE69823178D1 (de) 2004-05-19
NO995316L (no) 1999-11-01
CN1254345A (zh) 2000-05-24
NZ500620A (en) 2000-10-27
BR9809342A (pt) 2000-07-04
AU729910B2 (en) 2001-02-15
ZA983629B (en) 1998-11-04
EP0979240A1 (en) 2000-02-16
ATE264339T1 (de) 2004-04-15
HUP0002942A2 (hu) 2001-01-29
CA2287569A1 (en) 1998-11-12
RU2183642C2 (ru) 2002-06-20
WO1998050420A1 (en) 1998-11-12
US6534495B1 (en) 2003-03-18
EP0979240B1 (en) 2004-04-14
RU2002104026A (ru) 2004-04-27
ES2218827T3 (es) 2004-11-16
DK0979240T3 (da) 2004-07-26
KR20010012174A (ko) 2001-02-15
AU7652098A (en) 1998-11-27
NO995316D0 (no) 1999-11-01
PL336589A1 (en) 2000-07-03

Similar Documents

Publication Publication Date Title
ID22904A (id) Penghambat serin protease
ID18001A (id) Penghambat-penghambat protease
ID24410A (id) Protease alkalin
ID25897A (id) Variant-variant protease tersubstitusi banyak
NO995433D0 (no) Protease-inhibitorer
ID22849A (id) Penghambat-penghambat sulmafida-metaloprotease
ID29885A (id) Penghambat serina protease
NO995434L (no) Proteaseinhibitorer
ID16105A (id) Inhibitor-inhibitor serin protease
NO995435D0 (no) Protease-inhibitorer
NO995268D0 (no) Proteaseinhibitorer
DE69815952D1 (de) Poliergerät
DE69816146D1 (de) Poliervorrichtung
FR2772563B1 (fr) Pantoufle cousue
DE69806425D1 (de) Schlauchanordnungen
ID18797A (id) Penghambat-penghambat protease
KR970049319U (ko) 무한궤도형 흑판
MA26429A1 (fr) Inhibiteurs de protease
ATA195197A (de) Gartenbaustein
FIU970370U0 (fi) Liitäntäkeskus
NO970872D0 (no) Farseformer
BR9701096A (pt) Acertron iii
ATA118697A (de) Zielfernrohr
ATA161897A (de) Zielfernrohr
BR7700565U (pt) Overlap